Skip to content

Efficacy and safety of Zhenyuan capsule in improving the glucose metabolism of pre-diabetes patients: a randomized controlled trial

Efficacy and safety of Zhenyuan capsule in improving the glucose metabolism of pre-diabetes patients:a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034000
Enrollment
Unknown
Registered
2020-06-20
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-diabetes

Interventions

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Fasting venous blood glucose >=6.1 and =7.8 and <11.1 mmol/L; 2. Patients aged 18-65 years; 3. Patients with informed and voluntary consent.

Exclusion criteria

Exclusion criteria: 1. The patients with type 2 diabetes were previously diagnosed; 2. Patients who have participated in other clinical trials or received hypoglycemic drugs in the past 3 months; 3. Patients with cardiovascular and cerebrovascular adverse events in the past 6 months; 4. Patients with severe trauma, major infectious diseases, major organ functions or organic diseases and psychosis; 5. Patients who are allergic to known components of the test drug; 6. Women in pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
Diagnosed as diabetes;

Secondary

MeasureTime frame
Acute and chronic complications of diabetes;All-cause mortality;Hospitalized due to acute cardiovascular and cerebrovascular events;

Countries

China

Contacts

Public ContactShi Dazhuo

Xiyuan Hospital, Chinese Academy of traditional Chinese Medicine

shidazhuo@126.com+86 13911972856

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026